03:38 AM EST, 11/24/2025 (MT Newswires) -- Brian Taylor Slingsby, 10% Owner, Director, on November 20, 2025, sold 1,000,000 shares in Mineralys Therapeutics ( MLYS ) for $43,350,000. Following the Form 4 filing with the SEC, Slingsby has control over a total of 7,903,838 common shares of the company, with 7,903,838 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1933414/000193341425000156/xslF345X05/wk-form4_1763766476.xml